Peuschel Henrike, Ruckelshausen Thomas, Cavelius Christian, Kraegeloh Annette
Leibniz-Institute for New Materials (INM), Campus D2 2, 66123 Saarbruecken, Germany.
Biomed Res Int. 2015;2015:961208. doi: 10.1155/2015/961208. Epub 2015 Jun 1.
The development of safe engineered nanoparticles (NPs) requires a detailed understanding of their interaction mechanisms on a cellular level. Therefore, quantification of NP internalization is crucial to predict the potential impact of intracellular NP doses, providing essential information for risk assessment as well as for drug delivery applications. In this study, the internalization of 25 nm and 85 nm silica nanoparticles (SNPs) in alveolar type II cells (A549) was quantified by application of super-resolution STED (stimulated emission depletion) microscopy. Cells were exposed to equal particle number concentrations (9.2 × 10(10) particles mL(-1)) of each particle size and the sedimentation of particles during exposure was taken into account. Microscopy images revealed that particles of both sizes entered the cells after 5 h incubation in serum supplemented and serum-free medium. According to the in vitro sedimentation, diffusion, and dosimetry (ISDD) model 20-27% of the particles sedimented. In comparison, 10(2)-10(3) NPs per cell were detected intracellularly serum-containing medium. Furthermore, in the presence of serum, no cytotoxicity was induced by the SNPs. In serum-free medium, large agglomerates of both particle sizes covered the cells whereas only high concentrations (≥ 3.8 × 10(12) particles mL(-1)) of the smaller particles induced cytotoxicity.
安全工程纳米颗粒(NP)的研发需要在细胞水平上详细了解其相互作用机制。因此,NP内化的定量对于预测细胞内NP剂量的潜在影响至关重要,可为风险评估以及药物递送应用提供重要信息。在本研究中,通过应用超分辨率受激发射损耗(STED)显微镜对25 nm和85 nm二氧化硅纳米颗粒(SNP)在II型肺泡细胞(A549)中的内化进行了定量。将细胞暴露于每种粒径的相同颗粒数浓度(9.2×10¹⁰个颗粒·mL⁻¹)下,并考虑暴露期间颗粒的沉降。显微镜图像显示,在补充血清和无血清培养基中孵育5小时后,两种粒径的颗粒均进入细胞。根据体外沉降、扩散和剂量测定(ISDD)模型,20%-27%的颗粒发生沉降。相比之下,在含血清培养基中,每个细胞内检测到10²-10³个NP。此外,在血清存在的情况下,SNP未诱导细胞毒性。在无血清培养基中,两种粒径的大团聚物覆盖细胞,而只有高浓度(≥3.8×10¹²个颗粒·mL⁻¹)的较小颗粒诱导细胞毒性。